GlassScriptPhysician profile
Crystal D Gibson
NPI 1174578835
$9,596.06
in general payments reported to CMS, 2019-2025
15 companies · $3,407 in 2025
The $3,407 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,664 · 2022: $3,352 · 2023: $119 · 2024: $52.41 · 2025: $3,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,321 · Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,321.45 |
| Food and Beverage | $257.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8,987.13 | 2021-2025 | Nexplanon |
| Abbvie INC. | $187.93 | 2021-2023 | |
| Pfizer INC. | $84.74 | 2021-2024 | |
| Myovant Sciences INC. | $84.50 | 2021-2022 | |
| Biogen, INC. | $53.44 | 2025 | Zurzuvae |
| Corcept Therapeutics | $38.70 | 2023 | Korlym |
| Exeltis, USA INC. | $32.57 | 2025 | Slynd |
| Becton, Dickinson and Company | $24.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.80 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.53 | 2024 | Spravato |
| Astellas Pharma US INC | $14.21 | 2023 | Veozah |
| Baxter Healthcare | $13.49 | 2021 | |
| Esperion Therapeutics, INC. | $13.36 | 2021 | |
| Axonics, INC. | $13.00 | 2022 | |
| Sumitomo Pharma America, INC. | $12.77 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.